What is Muse?
Muse is a pioneering company in the wellness technology space, renowned for its research-grade EEG device. This innovative product passively monitors brain activity, translating it into auditory cues that guide users toward a state of calm and focus. By offering scientifically validated devices and programs, Muse empowers organizations to integrate mindfulness and meditation into their employee wellness initiatives, aiming to reduce stress, build resilience, and boost engagement. The company's mission is to make the intangible benefits of mental well-being tangible through advanced technology.
How much funding has Muse raised?
Muse has raised a total of $38.3M across 4 funding rounds:
Angel/Seed
$1.2M
Series A
$6M
Series B
$21.6M
Series C
$9.5M
Angel/Seed (2012): $1.2M, investors not publicly disclosed
Series A (2013): $6M, investors not publicly disclosed
Series B (2017): $21.6M supported by OMERS Ventures and Export Development Canada
Series C (2022): $9.5M featuring Alabaster and Export Development Canada
Key Investors in Muse
Alabaster
Alabaster, with a domain suggesting a focus on spiritual or philanthropic endeavors, participated in Muse's Series C funding. Their involvement may indicate a belief in the company's mission to improve well-being through technology.
Export Development Canada
Export Development Canada (EDC), a Canadian government Crown corporation, provided risk management and financing services, supporting Muse's Series C and Series B rounds. Their participation highlights support for innovative Canadian companies with global potential.
OMERS Ventures
OMERS Ventures, an investment group associated with pension plans, was a backer in Muse's Series B financing. Their investment suggests a strategic interest in technology companies with strong growth prospects.
What's next for Muse?
With the infusion of major enterprise-level capital, Muse is poised for significant expansion and further technological development. The recent strategic investment signals a commitment to scaling its operations and potentially broadening its product offerings or market reach. Future endeavors will likely focus on enhancing the core EEG technology, expanding its corporate wellness programs, and solidifying its position as a leader in the burgeoning field of neurotech for mental wellness. This strategic financing will be instrumental in driving innovation and achieving long-term growth objectives.
See full Muse company page
